EpiPen maker Mylan faces proposed class action lawsuit in U.S.

Mylan EpiPen

Pharmaceutical firm Mylan NV has been hit with a new proposed class action lawsuit in the U.S. over the price of its EpiPen allergy treatment, which shot up to more than $600 US for a two-pack of the device from less than $100 in 2007.



from CBC | Health News http://ift.tt/2oxMFUe

Aucun commentaire:

Enregistrer un commentaire